Works by Kurzrock, Razelle

Results: 355

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.

Published in:

2008

By:

Tsimberidou, Apóstolia Maria;
Estey, Elihu;
Sijin Wen;
Pierce, Sherry;
Kantarjian, Hagop;
Albitar, Maher;
Kurzrock, Razellé;
Tsimberidou, Apostolia Maria;
Wen, Sijin;
Kurzrock, Razelle

Publication type:

journal article

Mucin-1: a promising pan-cancer therapeutic target.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-01016-2

By:

Grewal, Udhayvir Singh;
Kurzrock, Razelle

Publication type:

Article

Retreatment after Secondary Resistance or Mixed Response: A Pilot Study.

Published in:

Oncology, 2013, v. 85, n. 6, p. 350, doi. 10.1159/000355691

By:

Naing, Aung;
Agarwal, Rishi;
Falchook, Gerald;
Hong, David S.;
Janku, Filip;
Wheler, Jennifer;
Fu, Siqing;
Kurzrock, Razelle

Publication type:

Article

Real-world characteristics and survival outcomes of patients with metastatic ALK fusion-positive solid tumors treated with standard-of-care therapies.

Published in:

Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf005

By:

Gadgeel, Shirish M;
Fajardo, Otto;
Barlesi, Fabrice;
Kim, Jeong Eun;
Kurzrock, Razelle;
Thomas, David M;
Jagtiani, Ritika;
Noe, Johannes;
Schwemmers, Sven;
Nikolaidis, Christos

Publication type:

Article

The Molecular Tumor Board Turns 10: The Age of Complexity.

Published in:

Oncologist, 2025, v. 30, n. 3, p. 1, doi. 10.1093/oncolo/oyae271

By:

Wahida, Adam;
Kurzrock, Razelle

Publication type:

Article

Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer Analysis.

Published in:

Oncologist, 2024, v. 29, n. 2, p. e213, doi. 10.1093/oncolo/oyad230

By:

Disel, Umut;
Sivakumar, Smruthy;
Pham, Tim;
Fleischmann, Zoe;
Anu, R I;
Sokol, Ethan S;
Kurzrock, Razelle

Publication type:

Article

Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors.

Published in:

Oncologist, 2023, v. 28, n. 2, p. e82, doi. 10.1093/oncolo/oyac180

By:

Jardim, Denis L F;
Millis, Sherri Z;
Ross, Jeffrey S;
Lippman, Scott;
Ali, Siraj M;
Kurzrock, Razelle

Publication type:

Article

Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns.

Published in:

Oncologist, 2021, v. 26, n. 9, p. 787, doi. 10.1002/onco.13844

By:

Israel, Mason A.;
Danziger, Natalie;
McGregor, Kimberly A.;
Murugesan, Karthikeyan;
Gjoerup, Ole;
Sokol, Ethan S.;
Tukachinsky, Hanna;
Kurzrock, Razelle;
Kato, Shumei;
Sicklick, Jason K.;
Nimeiri, Halla S.;
Oxnard, Geoffrey R.;
Ross, Jeffrey S.

Publication type:

Article

KRAS‐Mutated, Estrogen Receptor‐Positive Low‐Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery.

Published in:

Oncologist, 2021, v. 26, n. 4, p. e530, doi. 10.1002/onco.13702

By:

Kato, Shumei;
McFall, Thomas;
Takahashi, Kenta;
Bamel, Kasey;
Ikeda, Sadakatsu;
Eskander, Ramez N.;
Plaxe, Steven;
Parker, Barbara;
Stites, Edward;
Kurzrock, Razelle

Publication type:

Article

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics.

Published in:

Oncologist, 2021, v. 26, n. 4, p. e715, doi. 10.1002/onco.13694

By:

Jardim, Denis L.;
Millis, Sherri Z.;
Ross, Jeffrey S.;
Woo, Michelle Sue‐Ann;
Ali, Siraj M.;
Kurzrock, Razelle

Publication type:

Article

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions.

Published in:

Oncologist, 2021, v. 26, n. 1, p. e78, doi. 10.1634/theoncologist.2020-0509

By:

Jardim, Denis L.;
Millis, Sherri Z.;
Ross, Jeffrey S.;
Woo, Michelle Sue‐Ann;
Ali, Siraj M.;
Kurzrock, Razelle

Publication type:

Article

Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience.

Published in:

Oncologist, 2020, v. 25, n. 11, p. e1803, doi. 10.1002/onco.13532

By:

Bohan, Sandy S.;
Sicklick, Jason K.;
Kato, Shumei;
Okamura, Ryosuke;
Miller, Vincent A.;
Leyland‐Jones, Brian;
Lippman, Scott M.;
Kurzrock, Razelle

Publication type:

Article

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?

Published in:

Oncologist, 2020, v. 25, n. 2, p. 94, doi. 10.1634/theoncologist.2019-0636

By:

Adashek, Jacob J.;
Kato, Shumei;
Ferrara, Roberto;
Lo Russo, Giuseppe;
Kurzrock, Razelle

Publication type:

Article

Real‐World Toxicity Experience with BRAF/MEK Inhibitors in Patients with Erdheim‐Chester Disease.

Published in:

Oncologist, 2020, v. 25, n. 2, p. e386, doi. 10.1634/theoncologist.2019-0606

By:

Saunders, Ila M.;
Goodman, Aaron M.;
Kurzrock, Razelle

Publication type:

Article

The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its Match.

Published in:

Oncologist, 2019, v. 24, n. 1, p. 1, doi. 10.1634/theoncologist.2017-0519

By:

Subbiah, Vivek;
Kurzrock, Razelle

Publication type:

Article

Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer.

Published in:

Oncologist, 2018, v. 23, n. 11, p. 1300, doi. 10.1634/theoncologist.2017-0498

By:

Basho, Reva K.;
Yam, Clinton;
Gilcrease, Michael;
Murthy, Rashmi K.;
Helgason, Thorunn;
Karp, Daniel D.;
Meric‐Bernstam, Funda;
Hess, Kenneth R.;
Valero, Vicente;
Albarracin, Constance;
Litton, Jennifer K.;
Chavez‐MacGregor, Mariana;
Hong, David;
Kurzrock, Razelle;
Hortobagyi, Gabriel N.;
Janku, Filip;
Moulder, Stacy L.

Publication type:

Article

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma.

Published in:

Oncologist, 2018, v. 23, n. 5, p. 586, doi. 10.1634/theoncologist.2017-0479

By:

Ikeda, Sadakatsu;
Tsigelny, Igor F.;
Skjevik, Åge A.;
Kono, Yuko;
Mendler, Michel;
Kuo, Alexander;
Sicklick, Jason K.;
Heestand, Gregory;
Banks, Kimberly C.;
Talasaz, AmirAli;
Lanman, Richard B.;
Lippman, Scott;
Kurzrock, Razelle

Publication type:

Article

Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach.

Published in:

Oncologist, 2018, v. 23, n. 2, p. 171, doi. 10.1634/theoncologist.2017-0199

By:

Kato, Shumei;
Kurasaki, Kellie;
Ikeda, Sadakatsu;
Kurzrock, Razelle

Publication type:

Article

Debunking the Delusion That Precision Oncology Is an Illusion.

Published in:

Oncologist, 2017, v. 22, n. 8, p. 881, doi. 10.1634/theoncologist.2017-0040

By:

Subbiah, Vivek;
Kurzrock, Razelle

Publication type:

Article

Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center.

Published in:

Oncologist, 2017, v. 22, n. 6, p. 631, doi. 10.1634/theoncologist.2016-0517

By:

Sharabi, Andrew;
Kim, Sangwoo Shawn;
Kato, Shumei;
Sanders, Philip D.;
Patel, Sandip Pravin;
Sanghvi, Parag;
Weihe, Elizabeth;
Kurzrock, Razelle

Publication type:

Article

Dosing Three-Drug Combinations That Include Targeted Anti-Cancer Agents: Analysis of 37,763 Patients.

Published in:

Oncologist, 2017, v. 22, n. 5, p. 576, doi. 10.1634/theoncologist.2016-0357

By:

Nikanjam, Mina;
Liu, Sariah;
Yang, Jincheng;
Kurzrock, Razelle

Publication type:

Article

Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response.

Published in:

Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00435

By:

Guram, Kripa;
Nunez, Maria;
Einck, John;
Mell, Loren K.;
Cohen, Ezra;
Sanders, P. Dominick;
Miyauchi, Sayuri;
Weihe, Elizabeth;
Kurzrock, Razelle;
Boles, Sarah;
Sharabi, Andrew B.

Publication type:

Article

Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies.

Published in:

Cell Cycle, 2015, v. 14, n. 21, p. 3434, doi. 10.1080/15384101.2015.1090065

By:

Jain, Rajul K;
Hong, David S;
Naing, Aung;
Wheler, Jennifer;
Helgason, Thorunn;
Shi, Nai-Yi;
Gad, Yash;
Kurzrock, Razelle

Publication type:

Article

Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes.

Published in:

Cell Cycle, 2015, v. 14, n. 14, p. 2219, doi. 10.1080/15384101.2015.1041695

By:

Kurzrock, Razelle;
Giles, Francis J

Publication type:

Article

Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types.

Published in:

Cell Cycle, 2015, v. 14, n. 14, p. 2355, doi. 10.1080/15384101.2015.1053669

By:

Schwaederle, Maria;
Elkin, Sheryl K;
Tomson, Brett N;
Carter, Jennifer Levin;
Kurzrock, Razelle

Publication type:

Article

Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer.

Published in:

Cell Cycle, 2015, v. 14, n. 11, p. 1730, doi. 10.1080/15384101.2015.1033596

By:

Schwaederle, Maria;
Daniels, Gregory A;
Piccioni, David E;
Kesari, Santosh;
Fanta, Paul T;
Schwab, Richard B;
Shimabukuro, Kelly A;
Parker, Barbara A;
Kurzrock, Razelle

Publication type:

Article

VEGF and dual-EGFR inhibition in colorectal cancer.

Published in:

Cell Cycle, 2015, v. 14, n. 8, p. 1129, doi. 10.1080/15384101.2015.1022071

By:

Falchook, Gerald S;
Kurzrock, Razelle

Publication type:

Article

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.

Published in:

Cell Cycle, 2015, v. 14, n. 8, p. 1252, doi. 10.1080/15384101.2015.1014149

By:

Kato, Shumei;
Schwaederle, Maria;
Daniels, Gregory A;
Piccioni, David;
Kesari, Santosh;
Bazhenova, Lyudmila;
Shimabukuro, Kelly;
Parker, Barbara A;
Fanta, Paul;
Kurzrock, Razelle

Publication type:

Article

Anticoagulation-induced severe bleeding in a patient receiving bevacizumab therapy.

Published in:

2012

By:

Munoz, Javier;
Hong, David;
Kurzrock, Razelle

Publication type:

Editorial

Chronic myelogenous leukemia in chronic phase.

Published in:

2001

By:

Kurzrock, Razelle;
Kantarjian, Hagop;
Talpaz, Moshe;
Kurzrock, R;
Kantarjian, H;
Talpaz, M

Publication type:

journal article

Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown.

Published in:

Molecular Oncology, 2024, v. 18, n. 4, p. 956, doi. 10.1002/1878-0261.13293

By:

Kato, Shumei;
Gumas, Sophia;
Adashek, Jacob J.;
Okamura, Ryosuke;
Lee, Suzanna;
Sicklick, Jason K.;
Kurzrock, Razelle

Publication type:

Article

Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown.

Published in:

Molecular Oncology, 2024, v. 18, n. 4, p. 956, doi. 10.1002/1878-0261.13293

By:

Kato, Shumei;
Gumas, Sophia;
Adashek, Jacob J.;
Okamura, Ryosuke;
Lee, Suzanna;
Sicklick, Jason K.;
Kurzrock, Razelle

Publication type:

Article

Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population.

Published in:

Molecular Oncology, 2023, v. 17, n. 9, p. 1844, doi. 10.1002/1878-0261.13383

By:

Rosenberg, Shai;
Ben Cohen, Gil;
Kato, Shumei;
Okamura, Ryosuke;
Lippman, Scott M.;
Kurzrock, Razelle

Publication type:

Article

Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience.

Published in:

Molecular Oncology, 2022, v. 16, n. 13, p. 2575, doi. 10.1002/1878-0261.13202

By:

Louie, Bryan H.;
Shumei Kato;
Ki Hwan Kim;
Hyo Jeong Lim;
Lee, Suzanna;
Ryosuke Okamura;
Fanta, Paul T.;
Kurzrock, Razelle

Publication type:

Article

Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.

Published in:

Molecular Oncology, 2021, v. 15, n. 1, p. 67, doi. 10.1002/1878-0261.12791

By:

Charo, Lindsey M.;
Eskander, Ramez N.;
Okamura, Ryosuke;
Patel, Sandip P.;
Nikanjam, Mina;
Lanman, Richard B.;
Piccioni, David E.;
Kato, Shumei;
McHale, Michael T.;
Kurzrock, Razelle

Publication type:

Article

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.

Published in:

Molecular Oncology, 2020, v. 14, n. 8, p. 1680, doi. 10.1002/1878-0261.12748

By:

Pham, Timothy V.;
Boichard, Amélie;
Goodman, Aaron;
Riviere, Paul;
Yeerna, Huwate;
Tamayo, Pablo;
Kurzrock, Razelle

Publication type:

Article

Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden.

Published in:

Molecular Oncology, 2020, v. 14, n. 6, p. 1242, doi. 10.1002/1878-0261.12672

By:

Bieg‐Bourne, Cheyennedra C.;
Okamura, Ryosuke;
Kurzrock, Razelle

Publication type:

Article

Epidermal growth factor receptor mutation and diverse tumors: Case report and concise literature review

Published in:

Molecular Oncology, 2010, v. 4, n. 4, p. 306, doi. 10.1016/j.molonc.2010.03.002

By:

Chintala, Lakshmi;
Kurzrock, Razelle

Publication type:

Article

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.

Published in:

2018

By:

Sen, Shiraj;
Kato, Shumei;
Agarwal, Rishi;
Piha-Paul, Sarina;
Hess, Kenneth;
Karp, Daniel;
Janku, Filip;
Fu, Siqing;
Naing, Aung;
Pant, Shubham;
Falchook, Gerald;
Tang, Chad;
Wu, Xifeng;
Ye, Yuanqing;
Tsimberidou, Apostolia;
Subbiah, Vivek;
Kurzrock, Razelle;
Byers, Lauren;
Westin, Shannon;
Lim, JoAnn

Publication type:

journal article

Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.

Published in:

2018

By:

Maitland, Michael L.;
Piha-Paul, Sarina;
Falchook, Gerald;
Kurzrock, Razelle;
Nguyen, Ly;
Janisch, Linda;
Karovic, Sanja;
McKee, Mark;
Hoening, Elizabeth;
Wong, Shekman;
Munasinghe, Wijith;
Palma, Joann;
Donawho, Cherrie;
Lian, Guinan K.;
Ansell, Peter;
Ratain, Mark J.;
Hong, David

Publication type:

journal article

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma.

Published in:

2017

By:

Daud, Adil;
Kluger, Harriet M;
Kurzrock, Razelle;
Schimmoller, Frauke;
Weitzman, Aaron L;
Samuel, Thomas A;
Moussa, Ali H;
Gordon, Michael S;
Shapiro, Geoffrey I

Publication type:

journal article

Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.

Published in:

BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03293-3

By:

Adashek, Jacob J.;
Pandya, Chinmayi;
Maragakis, Nicholas J.;
De, Pradip;
Cohen, Philip R.;
Kato, Shumei;
Kurzrock, Razelle

Publication type:

Article

Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines.

Published in:

Supportive Care in Cancer, 2015, v. 23, n. 9, p. 2649, doi. 10.1007/s00520-015-2625-9

By:

Naing, Aung;
Dalal, Shalini;
Abdelrahim, Maen;
Wheler, Jennifer;
Hess, Kenneth;
Fu, Siqing;
Hong, David;
Janku, Filip;
Falchook, Gerald;
Ilustre, Alyson;
Ouyang, Fengying;
Kurzrock, Razelle

Publication type:

Article

Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: The M. D. Anderson Cancer Center experience.

Published in:

American Journal of Hematology, 2009, v. 84, n. 7, p. 408, doi. 10.1002/ajh.21423

By:

Vemulapalli, Sushma;
Chintala, Lakshmi;
Tsimberidou, Apostolia-Maria;
Dhillon, Navjot;
Lei, Xiudong;
Hong, David;
Kurzrock, Razelle

Publication type:

Article

The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab.

Published in:

Oncologist, 2015, v. 20, n. 7, p. 737, doi. 10.1634/theoncologist.2015-0065

By:

Busaidy, Naifa L.;
LoRusso, Patricia;
Lawhorn, Kristie;
Hess, Kenneth R.;
Habra, Mohammed Amir;
Fu, Siqing;
Hong, David S.;
Chen, Helen X.;
Doyle, Lawrence A.;
Kurzrock, Razelle;
Naing, Aung

Publication type:

Article

Molecular Tumor Board: The University of California San Diego Moores Cancer Center Experience.

Published in:

Oncologist, 2014, v. 19, n. 6, p. 631, doi. 10.1634/theoncologist.2013-0405

By:

Schwaederle, Maria;
Parker, Barbara A.;
Schwab, Richard B.;
Fanta, Paul T.;
Boles, Sarah G.;
Daniels, Gregory A.;
Bazhenova, Lyudmila A.;
Subramanian, Rupa;
Coutinho, Alice C.;
Ojeda‐Fournier, Haydee;
Datnow, Brian;
Webster, Nicholas J.;
Lippman, Scott M.;
Kurzrock, Razelle

Publication type:

Article

Incidence of Mucositis in Patients Treated With Temsirolimus-Based Regimens and Correlation to Treatment Response.

Published in:

Oncologist, 2014, v. 19, n. 4, p. 426, doi. 10.1634/theoncologist.2013-0231

By:

Liu, Xiaochun;
LoRusso, Patricia;
Mita, Monica;
Piha‐Paul, Sarina;
Hong, David S.;
Fu, Siqing;
McQuinn, Lacey;
Asatiani, Ekaterine;
Doyle, Lawrence A.;
Chen, Helen X.;
Hess, Kenneth R.;
Kurzrock, Razelle;
Naing, Aung

Publication type:

Article

Barriers to Study Enrollment in Patients With Advanced Cancer Referred to a Phase I Clinical Trials Unit.

Published in:

Oncologist, 2013, v. 18, n. 12, p. 1316, doi. 10.1634/theoncologist.2013-0202

By:

Fu, Siqing;
McQuinn, Lacey;
Naing, Aung;
Wheler, Jennifer J.;
Janku, Filip;
Falchook, Gerald S.;
Piha‐Paul, Sarina A.;
Tu, Dennis;
Howard, Adrienne;
Tsimberidou, Apostolia;
Zinner, Ralph;
Hong, David S.;
Kurzrock, Razelle

Publication type:

Article

Compliance in Early-Phase Cancer Clinical Trials Research.

Published in:

Oncologist, 2013, v. 18, n. 3, p. 308, doi. 10.1634/theoncologist.2012-0260

By:

Kurzrock, Razelle;
Stewart, David J.

Publication type:

Article

A Tale of Two Histiocytic Disorders.

Published in:

Oncologist, 2013, v. 18, n. 1, p. 2, doi. 10.1634/theoncologist.2012-0440

By:

Janku, Filip;
Munoz, Javier;
Subbiah, Vivek;
Kurzrock, Razelle

Publication type:

Article